[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
June 26, 2002

Preoperative β-Blocker Use and Mortality and Morbidity Following CABG Surgery in North America—Correction

JAMA. 2002;287(24):3212. doi:10.1001/jama.287.24.3212

Incorrect Figure Legend and Acknowledgment Omissions. The Original Contribution entitled "Thrombolytic Therapy vs Primary Percutaneous Coronary Intervention for Myocardial Infarction in Patients Presenting to Hospitals Without On-site Cardiac Surgery: A Randomized Controlled Trial" published in the April 17, 2002, issue of THE JOURNAL (2002;287:1943-1951) contained an error in the legend for Figure 2 (page 1947). The legend should have read, "Survival was significantly better (P = .03) in the group receiving percutaneous coronary intervention." In addition, the following persons were inadvertently omitted from the acknowledgment: Anil Fatterpaker, MD, and Stephen Plantholt, MD, St Agnes Hospital, Baltimore, Md; Muriel Gulasci, RN, Cape Cod Hospital, Hyannis, Mass; Patricia Wolcott, RN, Shady Grove Adventist Hospital, Rockville, Md; and Karen Liebermann, RN, Suburban Hospital, Bethesda, Md.